Consumption of excessive sodium is a direct cause of hypertension, which affects nearly 1 in 3 Americans. CDC’s next Public Health Grand Rounds, entitled Sodium Reduction: Time for Choice, will be webcast live from CDC headquarters in Atlanta, Georgia on Thursday, April 21st at 1 p.m. (EDT) at www.cdc.gov/about/grand-rounds. Dr. Darwin Labarthe, Director of CDC’s Heart Disease and Stroke Prevention Division, will lead a discussion with other experts on the consequences of too much sodium in the diet and the regulatory and technological context for the use of salt in our food supply. The session will also review current sodium control efforts such as the National Salt Reduction Initiative and food procurement policies, and separate fact from fiction to support actions needed to address this very real public health burden.
Controlling the amount of sodium is not as simple as removing salt shakers from tables. Much of the sodium in food comes from processing and restaurant use. A multi-pronged strategy is needed to address the health consequences of excessive sodium. Tune in to the CDC webcast to learn the facts and options for addressing this critical issue.
Showing posts with label heart disease. Show all posts
Showing posts with label heart disease. Show all posts
Friday, 15 April 2011
Friday, 22 October 2010
Aspirin Use for Primary Prevention Shows Big Savings
A new study printed in Current Medical Research and Opinion found that aspirin use for primary prevention of cardiovascular disease (CVD) could produce overall savings of $79.6 million dollars over 10 years for a base population of 1 million patients, while use for secondary prevention shows a savings of $32.2 million. Aspirin use for primary prevention was also shown to save $29 million in out of pocket costs, which is an immediate benefit for patients.
The study measured cost savings associated with aspirin use for the prevention of CVD. Savings are seen if this preventive service was increased to reflect current guidelines with the greatest savings for primary prevention (i.e. in those patients without CVD, but at risk). Current clinical guidelines recommend aspirin use for the primary prevention of heart disease in men and stroke in women.
In addition to producing millions of dollars in savings, the study reported that aspirin use for primary prevention of CVD would prevent 1273 heart attacks, 2184 angina events, and 565 ischemic strokes in a base population of 1 million patients. Aspirin use for the primary prevention of CVD is not just financially valuable – it saves lives.
Partnership for Prevention supports aspirin use for the primary prevention of heart disease and stroke. Partnership convenes the Aspirin Task Force (ATF), a multidisciplinary group of experts committed to promoting aspirin use for the primary prevention of cardiovascular disease. The ATF supports the USPSTF recommendations, and encourages men and women to speak to their health care provider to decide if aspirin use is right for them.
In addition to the aspirin initiative, Partnership’s National Commission on Prevention Priorities (NCPP) has identified aspirin use for primary prevention as one of the highest value clinical preventive services. In fact, the NCPP reports that if 90% of those who were recommendation to use aspirin did use aspirin, 45,000 lives per year would be saved.
This study, along with Partnership’s initiatives, shows the importance of aspirin use for the primary prevention of heart disease and stroke. In particular, the study reinforces the value of utilizing preventive services to benefit our healthcare system and society as a whole.
The study measured cost savings associated with aspirin use for the prevention of CVD. Savings are seen if this preventive service was increased to reflect current guidelines with the greatest savings for primary prevention (i.e. in those patients without CVD, but at risk). Current clinical guidelines recommend aspirin use for the primary prevention of heart disease in men and stroke in women.
In addition to producing millions of dollars in savings, the study reported that aspirin use for primary prevention of CVD would prevent 1273 heart attacks, 2184 angina events, and 565 ischemic strokes in a base population of 1 million patients. Aspirin use for the primary prevention of CVD is not just financially valuable – it saves lives.
Partnership for Prevention supports aspirin use for the primary prevention of heart disease and stroke. Partnership convenes the Aspirin Task Force (ATF), a multidisciplinary group of experts committed to promoting aspirin use for the primary prevention of cardiovascular disease. The ATF supports the USPSTF recommendations, and encourages men and women to speak to their health care provider to decide if aspirin use is right for them.
In addition to the aspirin initiative, Partnership’s National Commission on Prevention Priorities (NCPP) has identified aspirin use for primary prevention as one of the highest value clinical preventive services. In fact, the NCPP reports that if 90% of those who were recommendation to use aspirin did use aspirin, 45,000 lives per year would be saved.
This study, along with Partnership’s initiatives, shows the importance of aspirin use for the primary prevention of heart disease and stroke. In particular, the study reinforces the value of utilizing preventive services to benefit our healthcare system and society as a whole.
Tuesday, 18 May 2010
Prevention Leading to Fewer Heart Deaths, Inaccuracy of Translated Prescriptions Named Best/Worst Prevention Ideas of the Week
The positive impact improved treatment and more effective preventive measures are having on the death rate from coronary heart disease was named the “Best Prevention Idea of the Week,” while prescription labels inaccurately translated into Spanish was named the “Worst Prevention Idea of the Week."
The “Best/Worst” awards are announced each week in “Prevention Matters,” the blog of Partnership for Prevention. Nominees are submitted by Partnership staff as well as the general public, and are voted on by the staff. Partnership for Prevention is a nonpartisan organization of business, nonprofit and government leaders who are working to make evidence-based disease prevention and health promotion a national priority. More information is available at http://www.prevent.org/.
BEST
Prevention Gets Credit for Fewer Heart Deaths
Improved treatment, coupled with more effective preventive measures, may be having a positive impact on the death rate from coronary heart disease. Death rate data from the United States and Canada both indicate a drop in cardiovascular deaths. According to the American Heart Association, the annual death rate from coronary heart disease from 1996 to 2006 declined 36.4 percent and the actual death rate dropped 21.9 percent.
In Canada, according to a study in the May 12 issue of the Journal of the American Medical Association, the death rate from coronary heart disease in the province of Ontario fell by 35 percent from 1994 to 2005.
"The overall good news is that coronary heart mortality continued to go down despite people growing older," said study author Dr. Harindra C. Wijeysundera, a cardiologist at the Sunnybrook Health Sciences Centre Schulich Heart Centre in Toronto.
WORST
Translated prescriptions often wrong
Pharmacies that print prescription labels translated into Spanish often issue inaccurate or confusing instructions that could be potentially hazardous to a patient's health, according to a report in the May issue of Pediatrics journal. Researchers looked at 76 medicine labels generated by 13 different computer programs that many pharmacies use to make translations and found an overall error rate of 50 percent.
"It's not surprising, and it's something I experience in practice every day," said Dr. Alejandro Clavier, who works at Esperanza Health Center in Chicago's Little Village neighborhood on the Southwest Side.
The “Best/Worst” awards are announced each week in “Prevention Matters,” the blog of Partnership for Prevention. Nominees are submitted by Partnership staff as well as the general public, and are voted on by the staff. Partnership for Prevention is a nonpartisan organization of business, nonprofit and government leaders who are working to make evidence-based disease prevention and health promotion a national priority. More information is available at http://www.prevent.org/.
BEST
Prevention Gets Credit for Fewer Heart Deaths
In Canada, according to a study in the May 12 issue of the Journal of the American Medical Association, the death rate from coronary heart disease in the province of Ontario fell by 35 percent from 1994 to 2005.
"The overall good news is that coronary heart mortality continued to go down despite people growing older," said study author Dr. Harindra C. Wijeysundera, a cardiologist at the Sunnybrook Health Sciences Centre Schulich Heart Centre in Toronto.
WORST
Translated prescriptions often wrong
Pharmacies that print prescription labels translated into Spanish often issue inaccurate or confusing instructions that could be potentially hazardous to a patient's health, according to a report in the May issue of Pediatrics journal. Researchers looked at 76 medicine labels generated by 13 different computer programs that many pharmacies use to make translations and found an overall error rate of 50 percent.
"It's not surprising, and it's something I experience in practice every day," said Dr. Alejandro Clavier, who works at Esperanza Health Center in Chicago's Little Village neighborhood on the Southwest Side.
Friday, 30 April 2010
National Forum for Heart Disease and Stroke Prevention
On Monday and Tuesday the National Forum for Heart Disease and Stroke Prevention held its 8th annual meeting in Washington DC. The meeting focused on developing the will to prevent heart disease and stroke in the public and private sectors, including drawing attention to the recently released Institute of Medicine (IOM) reports on hypertension and sodium reduction.
Dr. David Fleming, the chair of the IOM Committee on Strategies to Reduce Sodium Intake and a member of Partnership for Prevention’s National Commission on Prevention Priorities (NCPP), presented information about actions that can be taken by food manufacturers, the federal government, and public health professionals to reduce the sodium content in foods. The sodium plenary session was timely, occurring a few days after Partnership’s congressional briefing on reducing sodium consumption.
Another highlight from the meeting was a session on connecting traditional and emerging communication approaches to change behavior. Dr. Rob Gould, President and CEO of Partnership, spoke about behavior change and exciting new methods of communication. Other panelists hailed from the CDC, NIH, and Pew Research Center.
The National Forum on Heart Disease and Stroke Prevention works to provide leadership and facilitate collaboration among those committed to preventing heart disease and stroke. Partnership participated in last year’s Forum Symposium on the Health Economics of Cardiovascular Disease, and recently joined as a Forum member. Partnership’s work in cardiovascular disease prevention includes its Aspirin Task Force , a multidisciplinary group of medical professionals committed to promoting aspirin for primary prevention of heart disease and stroke, as well as projects in its priority areas of tobacco cessation and control, and poor nutrition and physical inactivity (obesity). For more information on the Forum and the Annual Meeting, please click here.
Rebecca Doigan
Program Associate
Partnership for Prevention
Dr. David Fleming, the chair of the IOM Committee on Strategies to Reduce Sodium Intake and a member of Partnership for Prevention’s National Commission on Prevention Priorities (NCPP), presented information about actions that can be taken by food manufacturers, the federal government, and public health professionals to reduce the sodium content in foods. The sodium plenary session was timely, occurring a few days after Partnership’s congressional briefing on reducing sodium consumption.
Another highlight from the meeting was a session on connecting traditional and emerging communication approaches to change behavior. Dr. Rob Gould, President and CEO of Partnership, spoke about behavior change and exciting new methods of communication. Other panelists hailed from the CDC, NIH, and Pew Research Center.
The National Forum on Heart Disease and Stroke Prevention works to provide leadership and facilitate collaboration among those committed to preventing heart disease and stroke. Partnership participated in last year’s Forum Symposium on the Health Economics of Cardiovascular Disease, and recently joined as a Forum member. Partnership’s work in cardiovascular disease prevention includes its Aspirin Task Force , a multidisciplinary group of medical professionals committed to promoting aspirin for primary prevention of heart disease and stroke, as well as projects in its priority areas of tobacco cessation and control, and poor nutrition and physical inactivity (obesity). For more information on the Forum and the Annual Meeting, please click here.
Rebecca Doigan
Program Associate
Partnership for Prevention
Wednesday, 10 March 2010
Successful Workplace Wellness Programs, Weight Watchers Teaming Up With McDonald’s named Best/Worst Prevention Ideas of the Week
The study showing that workplace wellness programs work was named the “Best Prevention Idea of the Week,” while Weight Watchers teaming up with McDonald’s has been named “Worst Prevention Idea of the Week.”
The “Best/Worst” awards are announced each week in “Prevention Matters,” the blog of Partnership for Prevention. Nominees are submitted by Partnership staff as well as the general public, and are voted on by the staff. Partnership for Prevention is a nonpartisan organization of business, nonprofit and government leaders who are working to make evidence-based disease prevention and health promotion a national priority. More information is available at http://www.prevent.org.
BEST
Workplace wellness programs help employees lose weight and reduce their risk of heart disease, a new study shows. U.S. researchers followed 757 hospital workers who took part in a voluntary 12-week, team-based wellness program that focused on diet and exercise. Data on the participants' weight, lifestyle behavior and heart disease risk factors were collected at the start of the study, at the end of the wellness program and a year after the program ended. All participants had similar improvements in levels of physical activity, along with lower cholesterol and blood pressure levels, and reduced waist circumferences at program end and at one year, the findings showed.
WORST
McDonald’s and point-based diet company Weight Watchers will partner in New Zealand, with the Weight Watchers logo appearing on three select MCD products -- Chicken McNuggets, the Filet-O-Fish sandwich and a Sweet Chili Chicken wrap. It's the latest win for McDonald's in a campaign for a healthier image that dates back to 2004 -- and which has coincided with a major move in its stock price.
Subscribe to:
Posts (Atom)